Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astera Labs, Inc.ALAB · Entity 1853 | Director · Chief Executive Officer | August 17, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astera Labs, Inc.
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,266,665 |
Ending reported balance
After 2026-08-17 transaction · row 18
18 source rows · reconciled sequenceRow 1 · 2026-08-17 · Sale · Disposed 578 · Balance 1,356,717 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-08-17 · Sale · Disposed 1,049 · Balance 1,355,668 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-08-17 · Sale · Disposed 1,984 · Balance 1,353,684 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-08-17 · Sale · Disposed 1,057 · Balance 1,352,627 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-08-17 · Sale · Disposed 3,500 · Balance 1,349,127 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 6 · 2026-08-17 · Sale · Disposed 2,525 · Balance 1,346,602 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 7 · 2026-08-17 · Sale · Disposed 17,373 · Balance 1,329,229 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 8 · 2026-08-17 · Sale · Disposed 3,713 · Balance 1,325,516 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 9 · 2026-08-17 · Sale · Disposed 5,449 · Balance 1,320,067 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 10 · 2026-08-17 · Sale · Disposed 1,610 · Balance 1,318,457 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 11 · 2026-08-17 · Sale · Disposed 2,616 · Balance 1,315,841 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 12 · 2026-08-17 · Sale · Disposed 6,484 · Balance 1,309,357 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 13 · 2026-08-17 · Sale · Disposed 7,992 · Balance 1,301,365 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 14 · 2026-08-17 · Sale · Disposed 10,438 · Balance 1,290,927 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 15 · 2026-08-17 · Sale · Disposed 2,946 · Balance 1,287,981 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 16 · 2026-08-17 · Sale · Disposed 1,782 · Balance 1,286,199 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 17 · 2026-08-17 · Sale · Disposed 6,926 · Balance 1,279,273 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 18 · 2026-08-17 · Sale · Disposed 12,608 · Balance 1,266,665 F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person. F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 699,999 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 19
Holding and transaction disclosures are not merged.
1 source rowRow 19 · Balance 699,999 F20: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy Living Trust | 3,789,232 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 20
Holding and transaction disclosures are not merged.
1 source rowRow 20 · Balance 3,789,232 F21: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy 2021 Trust 1 | 700,000 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 21
Holding and transaction disclosures are not merged.
1 source rowRow 21 · Balance 700,000 F22: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy 2021 Trust 2 | 700,000 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 22
Holding and transaction disclosures are not merged.
1 source rowRow 22 · Balance 700,000 F23: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy 2022 Trust 1 | 450,001 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 23
Holding and transaction disclosures are not merged.
1 source rowRow 23 · Balance 450,001 F24: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy 2022 Trust 2 | 450,001 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 24
Holding and transaction disclosures are not merged.
1 source rowRow 24 · Balance 450,001 F25: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.
F2: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $351.7600 to $352.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $350.8850 to $351.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $348.8000 to $349.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $347.6800 to $348.6300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $346.6200 to $347.5600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $345.5900 to $346.5050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $344.5100 to $345.5000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $343.4100 to $344.4000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $342.4400 to $343.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $341.4300 to $342.3800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $340.2200 to $341.2150, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $339.2100 to $340.2000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F14: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $338.2000 to $339.1900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F15: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $337.2600 to $338.1850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F16: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $336.0450 to $337.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F17: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $335.2425 to $335.9750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F18: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.8100 to $334.8050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F19: The price reported in Column 4 is a weighted average price. The shares were sold as part of block trades for multiple security holders of the Issuer in multiple transactions at prices ranging from $333.3600 to $333.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F20: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F21: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F22: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F23: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F24: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F25: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2024 Filed Nov 25, 2024 23:01 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 28,511 | $103.53 | $2,951,877.83 |
DisclosureSEC source: 0001736297-24-000055 · wk-form4_1732575707.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 628,895 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 16,298 shares sold at prices ranging from $101.6650 to $102.5900, 91,566 shares sold at prices ranging from $102.7300 to $103.7263, 62,428 shares sold at prices ranging from $103.7300 to $104.6600, and 772 shares sold at prices ranging from $104.7700 to $104.7800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:01 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 28,511 | $103.53 | $2,951,877.83 |
DisclosureSEC source: 0001736297-24-000055 · wk-form4_1732575707.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 878,895 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 16,298 shares sold at prices ranging from $101.6650 to $102.5900, 91,566 shares sold at prices ranging from $102.7300 to $103.7263, 62,428 shares sold at prices ranging from $103.7300 to $104.6600, and 772 shares sold at prices ranging from $104.7700 to $104.7800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:01 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 28,511 | $103.53 | $2,951,877.83 |
DisclosureSEC source: 0001736297-24-000055 · wk-form4_1732575707.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 878,894 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 16,298 shares sold at prices ranging from $101.6650 to $102.5900, 91,566 shares sold at prices ranging from $102.7300 to $103.7263, 62,428 shares sold at prices ranging from $103.7300 to $104.6600, and 772 shares sold at prices ranging from $104.7700 to $104.7800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 21, 2024 Filed Nov 25, 2024 23:01 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 28,511 | $103.53 | $2,951,877.83 |
DisclosureSEC source: 0001736297-24-000055 · wk-form4_1732575707.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,471,498 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 16,298 shares sold at prices ranging from $101.6650 to $102.5900, 91,566 shares sold at prices ranging from $102.7300 to $103.7263, 62,428 shares sold at prices ranging from $103.7300 to $104.6600, and 772 shares sold at prices ranging from $104.7700 to $104.7800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 387 | $100.01 | $38,703.06 |
DisclosureSEC source: 0001736297-24-000048 · wk-form4_1731531844.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 907,401 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 383 | $100.01 | $38,303.03 |
DisclosureSEC source: 0001736297-24-000048 · wk-form4_1731531844.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 657,406 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 383 | $100.01 | $38,303.03 |
DisclosureSEC source: 0001736297-24-000048 · wk-form4_1731531844.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 657,406 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 383 | $100.01 | $38,303.03 |
DisclosureSEC source: 0001736297-24-000048 · wk-form4_1731531844.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 907,406 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 383 | $100.01 | $38,303.03 |
DisclosureSEC source: 0001736297-24-000048 · wk-form4_1731531844.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 907,405 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 383 | $100.01 | $38,303.03 |
DisclosureSEC source: 0001736297-24-000048 · wk-form4_1731531844.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,500,009 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in two transactions with 2,100 shares sold at a price of $100.0000 and 202 shares sold at a price of $100.0900. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 70,628 | $91.94 | $6,493,277.00 |
DisclosureSEC source: 0001736297-24-000044 · wk-form4_1731099853.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 907,788 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 2,700 shares sold at prices ranging from $86.5062 to $87.3600, 10,030 shares sold at prices ranging from $87.5360 to $88.5300, 28,523 shares sold at prices ranging from $88.5400 to $89.4800, 200,248 shares sold at prices ranging from $89.5400 to $90.5300, 11,710 shares sold at prices ranging from $90.5500 to $91.5200, 11,107 shares sold at prices ranging from $91.6000 to $92.5900, 28,646 shares sold at prices ranging from $92.8800 to $93.8700, 68,569 shares sold at prices ranging from $93.8800 to $94.8750, 8,435 shares sold at prices ranging from $94.8800 to $95.8700, 30,763 shares sold at prices ranging from $95.8800 to $96.8700, 16,695 shares sold at prices ranging from $96.8800 to $97.8600, and 6,357 shares sold at prices ranging from $97.8800 to $98.4600, inclusive. F3 · price: (Continued from Footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in Footnote 2. F9 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 70,631 | $91.94 | $6,493,552.81 |
DisclosureSEC source: 0001736297-24-000044 · wk-form4_1731099853.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 657,789 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 2,700 shares sold at prices ranging from $86.5062 to $87.3600, 10,030 shares sold at prices ranging from $87.5360 to $88.5300, 28,523 shares sold at prices ranging from $88.5400 to $89.4800, 200,248 shares sold at prices ranging from $89.5400 to $90.5300, 11,710 shares sold at prices ranging from $90.5500 to $91.5200, 11,107 shares sold at prices ranging from $91.6000 to $92.5900, 28,646 shares sold at prices ranging from $92.8800 to $93.8700, 68,569 shares sold at prices ranging from $93.8800 to $94.8750, 8,435 shares sold at prices ranging from $94.8800 to $95.8700, 30,763 shares sold at prices ranging from $95.8800 to $96.8700, 16,695 shares sold at prices ranging from $96.8800 to $97.8600, and 6,357 shares sold at prices ranging from $97.8800 to $98.4600, inclusive. F3 · price: (Continued from Footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in Footnote 2. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 70,631 | $91.94 | $6,493,552.81 |
DisclosureSEC source: 0001736297-24-000044 · wk-form4_1731099853.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 657,789 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 2,700 shares sold at prices ranging from $86.5062 to $87.3600, 10,030 shares sold at prices ranging from $87.5360 to $88.5300, 28,523 shares sold at prices ranging from $88.5400 to $89.4800, 200,248 shares sold at prices ranging from $89.5400 to $90.5300, 11,710 shares sold at prices ranging from $90.5500 to $91.5200, 11,107 shares sold at prices ranging from $91.6000 to $92.5900, 28,646 shares sold at prices ranging from $92.8800 to $93.8700, 68,569 shares sold at prices ranging from $93.8800 to $94.8750, 8,435 shares sold at prices ranging from $94.8800 to $95.8700, 30,763 shares sold at prices ranging from $95.8800 to $96.8700, 16,695 shares sold at prices ranging from $96.8800 to $97.8600, and 6,357 shares sold at prices ranging from $97.8800 to $98.4600, inclusive. F3 · price: (Continued from Footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in Footnote 2. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 70,631 | $91.94 | $6,493,552.81 |
DisclosureSEC source: 0001736297-24-000044 · wk-form4_1731099853.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 907,789 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 2,700 shares sold at prices ranging from $86.5062 to $87.3600, 10,030 shares sold at prices ranging from $87.5360 to $88.5300, 28,523 shares sold at prices ranging from $88.5400 to $89.4800, 200,248 shares sold at prices ranging from $89.5400 to $90.5300, 11,710 shares sold at prices ranging from $90.5500 to $91.5200, 11,107 shares sold at prices ranging from $91.6000 to $92.5900, 28,646 shares sold at prices ranging from $92.8800 to $93.8700, 68,569 shares sold at prices ranging from $93.8800 to $94.8750, 8,435 shares sold at prices ranging from $94.8800 to $95.8700, 30,763 shares sold at prices ranging from $95.8800 to $96.8700, 16,695 shares sold at prices ranging from $96.8800 to $97.8600, and 6,357 shares sold at prices ranging from $97.8800 to $98.4600, inclusive. F3 · price: (Continued from Footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in Footnote 2. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 70,631 | $91.94 | $6,493,552.81 |
DisclosureSEC source: 0001736297-24-000044 · wk-form4_1731099853.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 907,788 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 2,700 shares sold at prices ranging from $86.5062 to $87.3600, 10,030 shares sold at prices ranging from $87.5360 to $88.5300, 28,523 shares sold at prices ranging from $88.5400 to $89.4800, 200,248 shares sold at prices ranging from $89.5400 to $90.5300, 11,710 shares sold at prices ranging from $90.5500 to $91.5200, 11,107 shares sold at prices ranging from $91.6000 to $92.5900, 28,646 shares sold at prices ranging from $92.8800 to $93.8700, 68,569 shares sold at prices ranging from $93.8800 to $94.8750, 8,435 shares sold at prices ranging from $94.8800 to $95.8700, 30,763 shares sold at prices ranging from $95.8800 to $96.8700, 16,695 shares sold at prices ranging from $96.8800 to $97.8600, and 6,357 shares sold at prices ranging from $97.8800 to $98.4600, inclusive. F3 · price: (Continued from Footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in Footnote 2. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:04 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 70,631 | $91.94 | $6,493,552.81 |
DisclosureSEC source: 0001736297-24-000044 · wk-form4_1731099853.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,500,392 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 2,700 shares sold at prices ranging from $86.5062 to $87.3600, 10,030 shares sold at prices ranging from $87.5360 to $88.5300, 28,523 shares sold at prices ranging from $88.5400 to $89.4800, 200,248 shares sold at prices ranging from $89.5400 to $90.5300, 11,710 shares sold at prices ranging from $90.5500 to $91.5200, 11,107 shares sold at prices ranging from $91.6000 to $92.5900, 28,646 shares sold at prices ranging from $92.8800 to $93.8700, 68,569 shares sold at prices ranging from $93.8800 to $94.8750, 8,435 shares sold at prices ranging from $94.8800 to $95.8700, 30,763 shares sold at prices ranging from $95.8800 to $96.8700, 16,695 shares sold at prices ranging from $96.8800 to $97.8600, and 6,357 shares sold at prices ranging from $97.8800 to $98.4600, inclusive. F3 · price: (Continued from Footnote 2) The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in Footnote 2. F4 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:09 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,944 | $70.26 | $558,130.35 |
DisclosureSEC source: 0001736297-24-000040 · wk-form4_1729022963.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 728,420 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:09 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,944 | $70.26 | $558,130.35 |
DisclosureSEC source: 0001736297-24-000040 · wk-form4_1729022963.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 728,420 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:09 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,944 | $70.26 | $558,130.35 |
DisclosureSEC source: 0001736297-24-000040 · wk-form4_1729022963.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 978,420 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:09 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,944 | $70.26 | $558,130.35 |
DisclosureSEC source: 0001736297-24-000040 · wk-form4_1729022963.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 978,419 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:09 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,944 | $70.26 | $558,130.35 |
DisclosureSEC source: 0001736297-24-000040 · wk-form4_1729022963.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,571,023 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:09 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 7,947 | $70.26 | $558,341.12 |
DisclosureSEC source: 0001736297-24-000040 · wk-form4_1729022963.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 978,416 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. The shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,636 | $51.49 | $702,162.64 |
DisclosureSEC source: 0001736297-24-000034 · wk-form4_1727985929.xml · nonDerivative · entry 6 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 2 Disclosed balance after: 736,364 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 47,064 shares sold at prices ranging from $50.60 to $51.59, 33,154 shares sold at prices ranging from $51.60 to $52.58 and 1,600 shares sold at prices ranging from $52.71 to $52.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,636 | $51.49 | $702,162.64 |
DisclosureSEC source: 0001736297-24-000034 · wk-form4_1727985929.xml · nonDerivative · entry 5 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2022 Trust 1 Disclosed balance after: 736,364 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 47,064 shares sold at prices ranging from $50.60 to $51.59, 33,154 shares sold at prices ranging from $51.60 to $52.58 and 1,600 shares sold at prices ranging from $52.71 to $52.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7 · ownership.nature: These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,636 | $51.49 | $702,162.64 |
DisclosureSEC source: 0001736297-24-000034 · wk-form4_1727985929.xml · nonDerivative · entry 4 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 2 Disclosed balance after: 986,364 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 47,064 shares sold at prices ranging from $50.60 to $51.59, 33,154 shares sold at prices ranging from $51.60 to $52.58 and 1,600 shares sold at prices ranging from $52.71 to $52.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6 · ownership.nature: These shares are owned directly an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,637 | $51.49 | $702,214.13 |
DisclosureSEC source: 0001736297-24-000034 · wk-form4_1727985929.xml · nonDerivative · entry 3 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By 2021 Trust 1 Disclosed balance after: 986,363 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 47,064 shares sold at prices ranging from $50.60 to $51.59, 33,154 shares sold at prices ranging from $51.60 to $52.58 and 1,600 shares sold at prices ranging from $52.71 to $52.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,637 | $51.49 | $702,214.13 |
DisclosureSEC source: 0001736297-24-000034 · wk-form4_1727985929.xml · nonDerivative · entry 2 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 986,363 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 47,064 shares sold at prices ranging from $50.60 to $51.59, 33,154 shares sold at prices ranging from $51.60 to $52.58 and 1,600 shares sold at prices ranging from $52.71 to $52.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:05 UTC | Astera Labs, Inc. ALAB · Entity 1853 | SaleCommon Stock | 13,636 | $51.49 | $702,162.64 |
DisclosureSEC source: 0001736297-24-000034 · wk-form4_1727985929.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Living Trust Disclosed balance after: 4,578,967 F1 · kind: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024. F2 · price: The price reported in column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions with 47,064 shares sold at prices ranging from $50.60 to $51.59, 33,154 shares sold at prices ranging from $51.60 to $52.58 and 1,600 shares sold at prices ranging from $52.71 to $52.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 22, 2024 Filed Mar 22, 2024 20:37 UTC | Astera Labs, Inc. ALAB · Entity 1853 | ConversionSeries A Preferred Stock · Derivative | 66,288 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-035412 · ownership.xml · derivative · entry 8 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Living Trust Disclosed balance after: 0 Underlying: Common Stock · 66,288 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date. F1 · derivative.exercise_date: Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date. F1 · derivative.expiration_date: Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date. F2 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 22, 2024 Filed Mar 22, 2024 20:37 UTC | Astera Labs, Inc. ALAB · Entity 1853 | ConversionCommon Stock | 66,288 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-035412 · ownership.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Living Trust Disclosed balance after: 4,592,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock automatically converted into one share of Common Stock on a one-for-one basis, immediately prior to the closing of the Issuer's initial public offering. The shares of Series A Preferred Stock have no expiration date. F2 · ownership.nature: These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| January 24, 2024 Filed Mar 21, 2024 20:22 UTC | Astera Labs, Inc. ALAB · Entity 1853 | GrantCommon Stock | 2,704,335 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-034736 · ownership.xml · nonDerivative · entry 1 Mohan Jitendra · CIK 0001998053 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,704,335 F1 · date: This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. F2 · shares: These shares represent an award of restricted stock units ("RSUs") granted on January 24, 2024 under the Astera Labs, Inc. Amended and Restated 2018 Equity Incentive Plan. Such award vests upon satisfaction of both (i) a time-based condition, which provides that the RSUs shall vest as to 25% on February 15, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, and (ii) a performance-based condition, which is satisfied upon the occurrence of a change in control of the Issuer or the consummation of an initial public offering of the Issuer's equity securities, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.